Efficacy and safety of evogliptin in patients with type 2 diabetes and non-alcoholic fatty liver disease: A multicentre, double-blind, randomized, comparative trial
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Han, Eugene | - |
dc.contributor.author | Huh, Ji Hye | - |
dc.contributor.author | Lee, Eun Y. | - |
dc.contributor.author | Bae, Ji C. | - |
dc.contributor.author | Chun, Sung W. | - |
dc.contributor.author | Yu, Sung H. | - |
dc.contributor.author | Kwak, Soo H. | - |
dc.contributor.author | Park, Kyong S. | - |
dc.contributor.author | Lee, Byung-Wan | - |
dc.date.accessioned | 2022-03-29T02:40:14Z | - |
dc.date.available | 2022-03-29T02:40:14Z | - |
dc.date.issued | 2022-04 | - |
dc.identifier.issn | 1462-8902 | - |
dc.identifier.issn | 1463-1326 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/20560 | - |
dc.format.extent | 5 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Blackwell Publishing Inc. | - |
dc.title | Efficacy and safety of evogliptin in patients with type 2 diabetes and non-alcoholic fatty liver disease: A multicentre, double-blind, randomized, comparative trial | - |
dc.type | Article | - |
dc.publisher.location | 미국 | - |
dc.identifier.doi | 10.1111/dom.14623 | - |
dc.identifier.scopusid | 2-s2.0-85121698174 | - |
dc.identifier.wosid | 000734621400001 | - |
dc.identifier.bibliographicCitation | Diabetes, Obesity and Metabolism, v.24, no.4, pp 752 - 756 | - |
dc.citation.title | Diabetes, Obesity and Metabolism | - |
dc.citation.volume | 24 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 752 | - |
dc.citation.endPage | 756 | - |
dc.type.docType | Letter | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Endocrinology & Metabolism | - |
dc.relation.journalWebOfScienceCategory | Endocrinology & Metabolism | - |
dc.subject.keywordPlus | SITAGLIPTIN | - |
dc.subject.keywordPlus | MODEL | - |
dc.subject.keywordPlus | RISK | - |
dc.subject.keywordAuthor | dipeptidyl peptidase-4 inhibitor | - |
dc.subject.keywordAuthor | evogliptin | - |
dc.subject.keywordAuthor | magnetic resonance imaging-derived proton density fat fraction | - |
dc.subject.keywordAuthor | non-alcoholic fatty liver disease | - |
dc.subject.keywordAuthor | pioglitazone | - |
dc.subject.keywordAuthor | type 2 diabetes | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.